JANE STREET GROUP, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,331,960
-4.2%
124,003
+27.1%
0.00%0.0%
Q2 2023$3,477,920
+81.4%
97,530
+29.2%
0.00%0.0%
Q1 2023$1,917,623
+70.5%
75,497
+206.9%
0.00%0.0%
Q4 2022$1,124,932
-13.5%
24,600
-32.1%
0.00%0.0%
Q3 2022$1,300,000
-54.9%
36,208
-54.0%
0.00%0.0%
Q2 2022$2,884,000
-60.6%
78,778
-50.5%
0.00%
-50.0%
Q1 2022$7,314,000
-44.4%
159,051
-19.9%
0.00%
-33.3%
Q4 2021$13,159,000
+0.9%
198,463
-5.0%
0.00%
-25.0%
Q3 2021$13,037,000
-35.0%
208,812
-13.7%
0.00%
-55.6%
Q2 2021$20,043,000
+78.4%
242,004
+42.9%
0.01%
+50.0%
Q1 2021$11,232,000
-49.2%
169,387
-41.3%
0.01%
-50.0%
Q4 2020$22,131,000
+88.1%
288,421
+5.6%
0.01%
+71.4%
Q3 2020$11,764,000
-11.2%
273,198
-10.9%
0.01%
-30.0%
Q2 2020$13,242,000
+422.8%
306,607
+248.1%
0.01%
+233.3%
Q1 2020$2,533,000
-74.0%
88,081
-42.6%
0.00%
-78.6%
Q4 2019$9,734,000
+1450.0%
153,461
+588.8%
0.01%
+1300.0%
Q3 2019$628,000
-25.7%
22,280
-51.6%
0.00%0.0%
Q1 2019$845,000
+314.2%
46,052
+181.1%
0.00%
Q4 2018$204,000
-69.9%
16,385
-67.1%
0.00%
-100.0%
Q2 2018$677,000
+420.8%
49,779
+41.0%
0.00%
Q4 2017$130,00035,2990.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders